Xenomorph
  • Solutions
  • Technology
  • Customers
  • Resources
  • News
  • About Us
  • Request a Demo
  • Search
  • Menu Menu
  • Twitter
  • LinkedIn

News

RA Capital selects Xenomorph for Bio-Tech and Financial Data Management

New York, Boston, and London – July 5, 2022.  Having completed an extensive selection process and subsequent proof of concept, RA Capital selected Xenomorph to deliver a comprehensive enterprise data management solution for their bio-tech and financial data needs.

Xenomorph provided RA Capital with an enterprise data management platform that met their requirement for robustness, scalability and performance.  Xenomorph’s future-proof data model coupled with its support for all data vendors and ability to match companies and drugs from multiple data vendors were key to the platform’s selection.  The solution also enables the reconciliation of data from multiple sources and provides event notification to interested parties and systems.

“We were diligent in the selection of RA Capital’s data platform.  We wanted more than a standard security master, we wanted a true data platform product that can handle all types of data across industries, and providers.  Many products in the market are an offshore consultant team disguised as a product, we were careful to rule those out.  We ran a rigorous RFP process and a detailed POC before finally selecting Xenomorph”, Chris Caliri (CIO, RA Capital).

“Xenomorph’s ability to support complex hierarchical data structures with multiple relationships, across a variety of entities, was critical to the success of our project. Customizable data management rules allowed RA to merge and enrich company, person and drug data, across several internal and external data providers. The Xenomorph team was not only a dedicated implementation partner but also provided valuable guidance throughout the project”, Ernesto Gonzalez (Sr BSA, RA Capital).

“A key requirement was the ability to store biotechnology-related data, such as drugs, catalysts, events and clinical trial data as well as more standard security and price data.  This also included a complicated set of inter-relationships between various data elements.  Xenomorph’s ability to handle any type of data, over any frequency and from any industry – out of the box and without any changes to the product – proved to be critically advantageous to RA Capital”, Mark Woodgate (Founder, Xenomorph).

“The 300+ person years of R&D that have gone into the product enable a configuration over customization approach, ensuring a timely and on-budget implementation.  These principles, combined with RA Capital’s clear and precise guidance, were fundamental to the success of the project.  Xenomorph has cherished its initial involvement with RA Capital and we very much look forward to being part of their exciting future”, Naj Alavi (President, Xenomorph).

 

About Xenomorph

Xenomorph provides trusted data management solutions to many of the world’s leading financial institutions. The company has more than two decades’ experience managing large volumes of complex data and analytics. Over that time, we have consistently reinvested in our technology, culminating in our latest generation enterprise data management platform.

We empower businesses by delivering simple solutions to complex data management challenges. Our platform is built to manage the most sophisticated data management requirements, from pricing complex OTC-traded derivatives and running multi-factor investment models, through to managing risk factors globally for the biggest banks.

About RA Capital

RA Capital Management is a multi-stage investment manager dedicated to company formation and evidence-based investing in healthcare and life science companies developing drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization. We are committed to fostering diversity at RA, in our portfolio companies, and in the broader biotech community.

 

Contacts:

Matthew Pick

mpick@xenomorph.com

Chris Caliri

ccaliri@racap.com

Share this entry
  • Share on Twitter
  • Share on LinkedIn
  • Share by Mail
https://www.xenomorph.com/wp-content/uploads/2022-RA-Capital-Press-Release.jpg 628 1200 Matt Pick https://www.xenomorph.com/wp-content/uploads/2019/07/logo-xeno.png Matt Pick2022-07-06 09:27:392022-07-06 09:27:39RA Capital selects Xenomorph for Bio-Tech and Financial Data Management

Categories

  • Blog Post
  • Events
  • Press Release

Archives

About Xenomorph

Xenomorph provides trusted data management solutions to many of the world’s leading financial institutions.

With more than two decades’ experience managing large volumes of complex data and analytics we can quickly configure a solution for your requirements.

Xenomorph London

4th Floor
10 Lloyd’s Avenue
London EC3N 3AJ
UK

+44 (0)20 7614 8600

info@xenomorph.com

map

Xenomorph New York

45 Rockefeller Plaza, FL 20
New York
NY 10111
USA

+1-212-401-7894

info@xenomorph.com

map


Xenomorph Boston

53 State Street
Suite 500
Boston, MA 02109
USA

+1-617-465-2050

info@xenomorph.com

map

© Xenomorph Software Ltd 2022 - Privacy policy | Anti-Bribery Policy
Scroll to top
This website uses cookies to improve your experience. If you continue to use the site we will assume your consent. ACCEPTRead More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
SAVE & ACCEPT